{"url":"https://lda.senate.gov/api/v1/filings/991129ba-7bbb-4305-9fe5-e18f420cfdff/","filing_uuid":"991129ba-7bbb-4305-9fe5-e18f420cfdff","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2021,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/991129ba-7bbb-4305-9fe5-e18f420cfdff/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Thomas Jeffers","dt_posted":"2021-10-19T15:20:19.277000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1069 State Road 46 East","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Batesville","registrant_state":"IN","registrant_zip":"47006","registrant":{"id":400385786,"url":"https://lda.senate.gov/api/v1/registrants/400385786/","house_registrant_id":null,"name":"HILL-ROM HOLDINGS","description":"Medical device manufacturer","address_1":"1069 State Road 46 East","address_2":null,"address_3":null,"address_4":null,"city":"Batesville","state":"IN","state_display":"Indiana","zip":"47006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"THOMAS J. JEFFERS","contact_telephone":"+1 812-934-7958","dt_updated":"2022-04-06T16:07:37.446194-04:00"},"client":{"id":189909,"url":"https://lda.senate.gov/api/v1/clients/189909/","client_id":12,"name":"HILL-ROM HOLDINGS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-01-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations, government funding and program opportunities.  Labor-HHS FY 22 Appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46204,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"JEFFERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues regarding trade and supply chains.  Buy America policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46204,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"JEFFERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Corporate and international tax and tariff policy; Sec. S965 and GILTI","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46204,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"JEFFERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues regarding COVID short and long term chalenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation, supply chain issues; Medicare and Medicaid coverage and reimbursement; artifical intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives.  Hospital-at-Home. OSHA standards and rules related to vaccinations. S. 748, the Medciare Sequester Relief Act, H.R. 315, the Medciare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 4502 - FY2022 Consolidated Appropriations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46204,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"JEFFERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Veterans and Military Health, inclduing funding opportunities; VA procurement and payment reforms; prompt pay, veterans choice program issues. Buy America policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46204,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"JEFFERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding COVID short and long term chalenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation, supply chain issues; Medicare and Medicaid coverage and reimbursement; artifical intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives.  Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46204,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"JEFFERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}